评估胰腺CT影像生物标志物预测糖尿病的可靠性:一项双中心回顾性研究
该双中心回顾性研究纳入9772例有CT扫描及对应HbA1c检测的患者,使用三种胰腺分割算法测量平均衰减、胰腺内脂肪分数、胰腺边界分形维度和体积等影像生物标志物。基于衰减测量的标志物算法间一致性高(ICC≥0.93),预测糖尿病的AUC总体为0.84-0.91,阳性预测值0.79-0.84,阴性预测值0.89-0.94。结论认为基于衰减的影像生物标志物对分割算法质量稳健,在不同临床场景下具有一致预测能力。
要点
- 基于衰减测量的胰腺影像生物标志物在三种分割算法间一致性高(ICC≥0.93)。
- 基于影像标志物预测糖尿病的AUC总体为0.84-0.91,阳性预测值0.79-0.84,阴性预测值0.89-0.94。
- 非衰减依赖的标志物算法间一致性较低;非增强扫描预测AUC为0.62-0.80,低于增强扫描的0.73-0.80。
核心结论
- 基于衰减的影像生物标志物对分割算法质量稳健,在不同临床场景下预测能力一致;CT衍生标志物可能是跨机构糖尿病筛查的可靠工具。
研究设计与样本
- 双中心回顾性研究,纳入9772例有CT扫描及对应HbA1c检测的患者(年龄56.1岁±9.1,女性5407例),使用TotalSegmentator、nnU-Net和DM-UNet三种胰腺分割算法测量影像生物标志物,以扫描时或扫描后<4年内患糖尿病(糖尿病/新发)与扫描后4年内未患糖尿病(非糖尿病)分类,采用广义相加模型评估算法间预测一致性。
诊断标准与关键数值
- 基于衰减测量的影像生物标志物算法间一致性高(ICC≥0.93),非衰减依赖测量一致性较低;预测糖尿病AUC总体0.84-0.91,增强扫描0.73-0.80,非增强扫描0.62-0.80;阳性预测值0.79-0.84,阴性预测值0.89-0.94。
临床应用与阅片要点
- 作者认为CT衍生生物标志物可能是跨机构糖尿病筛查的可靠工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Pancreatic imaging biomarkers on CT imaging are known to be associated with diabetes. However, no studies have examined if these imaging biomarkers are resilient to changes in segmentation quality and contrast status. Here, we assess if imaging biomarkers are robust to variations in pancreatic segmentation quality and contrast status, and how these factors affect their ability to predict diabetes.
MATERIALS AND METHODS: This retrospective study selected patients with CT scans and corresponding HbA1c tests from two institutions. Patients were classified into two categories: having diabetes at the time or < 4 years after the scan (diabetic/incident) vs not having diabetes within 4 years after the scan (nondiabetic). Pancreatic imaging biomarkers, including average attenuation, intrapancreatic fat fraction, fractal dimension of the pancreatic boundary and volume, were measured using three pancreatic segmentation algorithms (TotalSegmentator, nnU-Net, and DM-UNet). Pairwise comparisons were made between algorithms when computing pancreatic imaging biomarker values for all patient scans. Predictive ability of imaging biomarkers (derived from each algorithm) was assessed for agreement between algorithms using a generalized additive model.
RESULTS: A total of 9772 patients (age, 56.1 years ± 9.1 [SD]; 5407 females) were included in this study. Imaging biomarkers based on attenuation measurements showed high algorithm agreement (ICC ≥0.93), with lower agreement on measures not reliant on attenuation. Models trained on imaging biomarkers derived from these algorithms exhibited good predictive agreement (AUC for diabetes overall, 0.84-0.91; contrast scans, 0.73-0.80; noncontrast scans, 0.62-0.80). Algorithms achieved a positive predictive value of 0.79-0.84, and negative predictive value of 0.89-0.94.
CONCLUSION: Attenuation-based imaging biomarkers demonstrated robustness to segmentation algorithm quality and consistent predictive ability across different clinical scenarios. These findings suggest that CT-derived biomarkers could be a reliable tool for diabetes screening across multiple institutions.
引用
- Suri A, Mukherjee P, Rabbee N, et al. Assessing the Reliability of Pancreatic CT Imaging Biomarkers for Diabetes Prediction: A Dual Center Retrospective Study. Acad Radiol. 2025. PMID: 40121118. doi:10.1016/j.acra.2025.02.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。